UNSPSC 51373436: Citric/codeine/ipecac/potassium/promethazine/sodium citrate

This classification denotes a combination drug defined by the U.S. Department of Veterans Affairs in its (VA's) National Drug File (NDF), which falls under VA Drug Class RE301. This VA Drug Class (RE301) classifies this compound as belonging to the group OPIOID-CONTAINING ANTITUSSIVES/EXPECTORANTS.

UNSPSC 51373436 Citric/codeine/ipecac/potassium/promethazine/sodium citrate is a Commodity code capturing pharmaceutical active ingredients and formulations that state and local governments procure for clinical and emergency-response use. Recent state and local solicitations show purchasing activity centered on parenteral products (intravenous solutions, parenteral nutrition, controlled substances for medical administration) and opioid-reversal agents (naloxone) used in correctional health care and community health initiatives. The Washington State Department of Corrections and Seminole County, Florida have each issued active solicitations for these products in the past four months. Issuing bodies under this code include state correctional departments and county health agencies, reflecting procurement driven by mandatory healthcare delivery obligations and public-health emergency-response mandates.

Geographic activity centers on Washington and Florida based on recent postings. The Washington State Department of Corrections issued RFQ RFQQK13020 on September 8, 2026, with a due date of October 7, 2026, for parenteral products, services, and equipment to supply eight correctional facilities across Washington's West, Central, and East regions; the scope explicitly includes parenteral nutrition solutions, intravenous solutions, and controlled substances, with expedited delivery requirements (24-hour turnaround for PN bags, 8-hour turnaround for other products). Washington's solicitation encourages participation from small, minority-owned, women-owned, and veteran-owned businesses under state set-aside goals and requires compliance with Chapter 39.19 RCW regarding disadvantaged-business utilization. Seminole County, Florida issued IFB 60459723LAS on June 30, 2026, for annual procurement of 1,900 units of naloxone and 800 safe drug deactivation systems with quarterly deliveries and a two-year initial term plus one-year renewal option. Both solicitations specify fixed pricing and vendor insurance requirements; the Washington solicitation permits multiple award decisions (up to three bidders per region), while Seminole County's procurement involves FEMA funding and corresponding federal compliance obligations.